These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 15536919)

  • 1. Barrier to trade or barrier to profit? Why Australia's Pharmaceutical Benefits Scheme worries U.S. drug companies.
    Hamilton C; Lokuge B; Denniss R
    Yale J Health Policy Law Ethics; 2004; 4(2):373-85. PubMed ID: 15536919
    [No Abstract]   [Full Text] [Related]  

  • 2. Australia-United States Free Trade Agreement and the Australian Pharmaceutical Benefits Scheme.
    Sainsbury P
    Yale J Health Policy Law Ethics; 2004; 4(2):387-99. PubMed ID: 15536920
    [No Abstract]   [Full Text] [Related]  

  • 3. Australian pharmaceutical policy: price control, equity, and drug innovation in Australia.
    Doran E; Alexander Henry D
    J Public Health Policy; 2008 Apr; 29(1):106-20. PubMed ID: 18368023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. If foreign drug prices go up, will U.S. prices come down?
    Med Health; 2003 Dec; 57(45):2-4. PubMed ID: 14723168
    [No Abstract]   [Full Text] [Related]  

  • 5. Patents, pills and politics: the Australia-United States Free Trade Agreement and the Pharmaceutical Benefits Scheme.
    Harvey K
    Aust Health Rev; 2004 Nov; 28(2):218-26. PubMed ID: 15527402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rx: higher prices.
    Kosterlitz J
    Natl J (Wash); 1993 Feb; 25(7):396-9. PubMed ID: 10125572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare should bargain for lower drug prices, study says.
    Med Health; 2005 Oct; 59(36):1, 3, 7. PubMed ID: 16240494
    [No Abstract]   [Full Text] [Related]  

  • 8. Commerce: Market-set drug prices abroad wouldn't cut U.S. prices.
    Med Health; 2005 Jan; 59(1):1-2. PubMed ID: 15672563
    [No Abstract]   [Full Text] [Related]  

  • 9. Support for trials of promising medications through the Pharmaceutical Benefits Scheme. A proposal for a new authority category.
    Glasziou PP
    Med J Aust; 1995 Jan; 162(1):33-6. PubMed ID: 7605432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reference pricing for pharmaceuticals: is the Australia-United States Free Trade Agreement affecting Australia's Pharmaceutical Benefits Scheme?
    Faunce TA
    Med J Aust; 2007 Aug; 187(4):240-2. PubMed ID: 17564579
    [No Abstract]   [Full Text] [Related]  

  • 11. As drug payment model changes, confusion grows among insurers.
    Sipkoff M
    Manag Care; 2007 Feb; 16(2):56-9. PubMed ID: 17361511
    [No Abstract]   [Full Text] [Related]  

  • 12. Australian drugs scheme threatens free-trade talks.
    Fickling D
    Lancet; 2004 Jan; 363(9405):299. PubMed ID: 14753208
    [No Abstract]   [Full Text] [Related]  

  • 13. Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia.
    Morgan S; McMahon M; Greyson D
    Health Policy; 2008 Aug; 87(2):133-45. PubMed ID: 18295927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competition and antitrust enforcement in the changing pharmaceutical marketplace.
    Whitener MD
    Food Drug Law J; 1995; 50(2):301-7. PubMed ID: 10342998
    [No Abstract]   [Full Text] [Related]  

  • 15. Australian drug pricing scheme under pressure in free trade talks.
    Burton B
    BMJ; 2004 Jan; 328(7434):247. PubMed ID: 14751890
    [No Abstract]   [Full Text] [Related]  

  • 16. Australian trade agreement to start Jan. 1, but battles loom.
    Med Health; 2004 Dec; 58(43):5-6. PubMed ID: 15612467
    [No Abstract]   [Full Text] [Related]  

  • 17. When success sours: PBMs under scrutiny.
    Carroll J
    Manag Care; 2002 Sep; 11(9):20-6. PubMed ID: 12369344
    [No Abstract]   [Full Text] [Related]  

  • 18. Doubts emerge about drug industry mergers.
    Bus Health; 1994 Nov; 12(11):53-4, 56, 61. PubMed ID: 10138536
    [No Abstract]   [Full Text] [Related]  

  • 19. Australia's free trade deal with US hangs in balance on drugs.
    Burton B
    BMJ; 2004 Aug; 329(7461):310. PubMed ID: 15297336
    [No Abstract]   [Full Text] [Related]  

  • 20. Why Canada won't be our pharmacy.
    Thottam J
    Time; 2004 Nov; 164(21):63. PubMed ID: 15597777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.